ventional peranal methods. [1] [2] [3] [4] in the united states, tem is primarily performed by a small number of high-volume specialists. 5 nearly 30 years after its introduction, this advanced transanal platform has not achieved widespread adoption because of costly, complex instrumentation, as well as a steep learning curve and the requirement for specialized training to master tem. 6, 7 notwithstanding, tem offers the ability to perform high-quality excisions with outcomes that have been shown to be more favorable than standard peranal techniques for local excision. [8] [9] [10] [11] transanal minimally invasive surgery (tamis) is a technique first developed in 2009 for local excision of well-selected rectal neoplasia. 12 initially facilitated by existing single-port surgery devices, 2 platforms for transanal access, the GelPoint Path (applied medical, Rancho santa margarita, Ca) and sils Port (Covidien, mansfield, ma) have recently gained food and Drug administration approval for tamis. since its initial description, small series and case reports have shown tamis to be a feasible, low-cost alternative to tem. [13] [14] [15] [16] [17] [18] [19] [20] Despite its increasing use, the efficacy of local excision using tamis has not yet been proven.
METHODS
from July 2009 to December 2011, a registry was created and, with institutional review board approval, data was prospectively collected on consecutive patients undergoing tamis excision for benign and malignant lesions of the rectum. follow-up consisted of complete clinical evaluation and examination, including rigid proctosigmoidoscopy in the out-patient setting. for the study group, follow-up extended to July 2012. Patient selection included those patients with benign adenomas, neuroendocrine tumors less than 2 cm in diameter, and well-differentiated ut1n0 invasive carcinoma less than 3 cm in diameter without evidence of lymphovascular invasion. During the study period, 4 patients with very distal lesions (within 2 cm of the dentate line) were not offered tamis and, instead, underwent conventional local excision. for patients with severe comorbid conditions for which curative-intent, standard oncologic resection (abdominoperineal resection or low anterior resection) was contraindicated, tamis local excision was performed as an alternative. for such patients with severe comorbidity, tamis was performed on more advanced lesions, including those staged with ut2n0 and ut3n0 lesions, as well as histologically unfavorable ut1n0 lesions. additionally, patients with clinical complete pathologic response to neoadjuvant treatment on preoperative endoscopic evaluation were also given the option of tamis local excision to confirm mural sterilization (ypt0).
Patients with invasive neoplasms were staged preoperatively with endorectal ultrasound and pelvic 3-tesla (3t) mRi. tumor location was determined by digital examina-tion and preoperative rigid proctoscopy; the position and dimension of the lesion was recorded and logged into a data registry. Preoperative pathologic diagnosis and postoperative final pathologic diagnosis were recorded for each patient.
surgical procedures were performed by 3 attending surgeons at a tertiary-care hospital. all patients were administered general endotracheal anesthesia with pharmacologic paralysis. surgery was performed in the high dorsal lithotomy position, with the exception of 1 patient whose anterior lesion was excised in the prone position. mechanical bowel preparation was administered preoperatively. according to surgical Care improvement Project protocol, a second generation cephalosporin and metronidazole or, alternatively, single-dose ertapenem (invanz) was administered parenterally 30 minutes before incision.
after insertion of the transanal port (either the sils Port or GelPoint Path), pneumorectum was established by using Co 2 insufflation with an initial pressure set at 15 mmhg and flow set at 40 mmhg per minute. high-definition laparoscopic cameras and a 30° or 45° 5-mm camera lens were used for visualization. standard laparoscopic instruments were used to perform excision. full-thickness excision was performed on all malignant lesions with the objective of obtaining a 1-cm minimum negative margin. Partial-thickness or submucosal excision was performed at the discretion of the operating surgeon for patients with morphologically benign appearing adenomas. all defects were closed completely with absorbable suture material by use a variety of suturing techniques.
Patients had a planned discharge for the same day of surgery and were selectively admitted postoperatively, depending on case complexity and patient comorbidity. Postoperatively, length of stay and early and late complications were also noted. Patients undergoing tamis resection were recommended to undergo aggressive follow-up, with quarterly physical examination, anoscopy, proctoscopy, Cea level assessment, as well as standard evidencebased surveillance as recommended by current national Comprehensive Cancer network guidelines.
RESULTS
fifty consecutive patients underwent tamis resection of benign and malignant rectal lesions from July 2009 to December 2011. this consisted of 17 women (34%) and 33 men (66%) with an average age of 64 years (range, 43-88) (table 1). tamis was successfully completed in all cases in the high dorsal lithotomy position, with the exception of 1 patient who was placed prone jack-knife. the latter positioning was chosen during our initial experience with tamis when the advantage of dorsal lithotomy for all patients, regardless of tumor orientation, was not yet fully appreciated.
the average total operating time was 74.9 minutes (range, 18-192 minutes). although no major technical difficulty was encountered during tamis resection, transient rectal lumen collapse occurred in some patients. this was overcome with either pharmacologic paralysis, increasing Co 2 insufflation pressure to 20 mmhg, or port adjustment.
the average length of stay was 0.6 days (range, 0-6) with 34 of 50 patients (68%) discharged on the same day of their surgery. five patients (10%) spent 3 or more days hospitalized postoperatively. the longest postoperative hospital stay was 6 days, in a patient with severe chronic obstructive pulmonary disease. of the 2 patients that were hospitalized for 5 days, 1 patient underwent laparoscopic low anterior resection following tamis excision for a pt2 lesion, thus accounting for her extended length of stay.
the average distance of tumor from the anal verge to the most distal aspect of the tumor was 8.2 cm (range, 3-14 cm), measured preoperatively on rigid proctoscopy. twenty-seven patients (54%) had tumors >8 cm from the anal verge, and 23 patients (46%) had tumors <8 cm from the anal verge (table 2) . of the 50 patients, 25 (50%) had benign lesions (23 adenoma, 2 hyperplastic), 23 (46%) had malignant lesions, and 2 (4%) patients had neuroendocrine tumors. of the 23 patients with malignant pathology, 1(4%) had intramucosal (tis) carcinoma, 16 (70%) had pt1 lesions, 3 (13%) had pt2 lesions, and 3 (13%) had pt3 lesions confirmed on final pathologic diagnosis (table 3) . of 50 specimens retrieved, only 2 (4%) were fragmented. six of 16 patients with pt1 tumors (38%) presented following endoscopic polypectomy with pathology revealing pt1 adenocarcinoma. these 6 patients underwent tamis for reexcision, and were all found to have no residual tumor on final pathology. of the 3 patients with t2 lesions, 1 patient was understaged preoperatively with a ut1 tumor and found to have a completely excised pt2 lesion after tamis excision. this patient proceeded with laparoscopic low anterior resection within 48 hours without adverse sequelae; in this case, there was no evidence of nodal metastasis. of the remaining 2 patients with pt2 adenocarcinoma, one refused further therapy beyond local excision, and the other had significant end-stage comorbidities prohibiting radical resection. three patients were found to have pt3 invasive adenocarcinoma after tamis excision. two of these patients subsequently underwent neoadjuvant chemoradiation, without delay, followed by low anterior resection. the third patient, an 86-year-old man with prohibitive comorbidities, declined further treatment. of the 23 patients with malignant tumors, only 2 patients (1 pt2 lesion and 1 pt3 lesion) underwent palliative tamis excision without curative intent.
all tumors were removed with grossly negative margins; however, 3 specimens (6%) were found to have microscopically positive margins. of the 3 patients with positive margins, 2 patients had excision for a villous adenoma and 1 patient had excision for a pt2 adenocarcinoma overall, excluding patients who proceeded to radical surgery, there have been 2 documented recurrences at follow-up, giving a recurrence rate thus far of 4.3%. one recurrence was documented in the above-mentioned villous adenoma with positive margins on initial excision. this recurrence occurred 18 months after tamis excision. the other recurrence occurred in a pt1 sm3 adenocarcinoma that was excised with negative margins. this patient did have lymphovascular invasion noted on initial pathologic evaluation, but, because of severe comorbidities, radical resection was contraindicated. this patient had a recurrence 6 months after the initial tamis excision. the patient presented with rectal bleeding, and colonoscopy revealed a recurrence at the previous resection site. tamis reexcision for his recurrent adenocarcinoma was performed. Pathologic evaluation demonstrated a completely resected pt3 lesion with closest negative margin measured at 1 cm. in this case, a portion of the mesorectal envelope was also removed during tamis, and 1 benign lymph node was obtained with the specimen.
there was no mortality after tamis local excision. early postoperative morbidity occurred in 4 patients (8%) (table 4). one patient required readmission for postoperative hemorrhage 2 weeks after the initial excision. Bleeding in this case was self-limited and required no blood transfusions or need for further surgical intervention, and, on visualization, had no suture line dehiscence. one patient had intraoperative scrotal emphysema that resolved in the recovery room. there was 1 incident of peritoneal entry that occurred during excision of a proximal anterior villous adenoma. the defect was sutured transanally, without adverse outcome and without conversion from tamis. one patient with underlying chronic pulmonary disease had prolonged (6 day) hospital stay postoperatively owing to chronic obstructive pulmonary disease exacerbation. there were no occurrences of urinary retention. there were also no incidences of anorectal dysfunction, although manometric studies were not obtained. at 20-month median follow-up (table 5) , no long-term complications due to tamis local excision were noted.
DISCUSSION
the approach to local excision for neoplasia of the extraperitoneal rectum has radically evolved since its first description in 1826 by Jacques lisfranc, 21 to subsequent peranal techniques, [22] [23] [24] [25] [26] such as the Parks excision, 27 to advanced transanal platforms which include tem, 28 transanal endoscopic operation (teo), 29, 30 and, most recently, tamis. 12 the indications for tamis are the same as for tem/ teo. 31 these indications include resection of benign rectal neoplasms and, for curative-intent surgery, well-selected t1 cancers, with histologically favorable features, where the risk of nodal metastasis is low. 32 the indication for tamis (and tem) may also be broadened to include local excision of ct0 lesions in patients with locally advanced rectal cancer after neoadjuvant therapy for the pur-pose of confirming mural complete pathologic response (ypt0). [33] [34] [35] this may be a valid option as the risk of occult node positivity for ypt0 lesions is reasonably low, at 3% to 6%. [36] [37] [38] in the united states, the rate of local excision for t1 rectal cancer has nearly doubled, and the rate of local excision for t2 lesions has tripled since 1989. 39 this dramatic increase has occurred, despite evidence that conventional (Parks) local excision of even histologically favorable stage i rectal cancer results in poor locoregional control, with or without adjuvant chemoradiation. [40] [41] [42] Conversely, data reveal that local excision, when performed on appropriately selected patients and when using an advanced transanal platform (tem) for early-stage (t1) rectal cancer, results in excellent survival and low recurrence rates, with outcomes comparable to radical resection. [43] [44] [45] [46] lezoche et al [47] [48] [49] described similar outcomes for t2 cancers with the addition of neoadjuvant chemoradiation proceeding a tem assisted volumetric resection. furthermore, recurrence-free survival has been shown to be significantly higher with tem in comparison with standard Parks local excision, presumably because the quality of resection is superior. 10 these data indicate that local excision mandates careful patient selection, as well as a high-quality resection facilitated by 1 of the 3 available advanced transanal platforms (tem/teo/tamis). as suggested by tem-experienced surgeons, tamis is an advanced platform that offers a promising alternative to tem and that, because of a cost advantage, may become superior to tem in the future. 14 indeed the cost of the single-use ports used for tamis ($500-$650 usD) is nearly equivalent to the cost of the specialized tem Co 2 tubing required for each tem case. 12, 14 other advantages of tamis over tem include rapid set-up time, 360° vs 220° of visibility within the rectal lumen, the ability to universally adapt any existing laparoscopic instrument, and the ease of lithotomy positioning within the operating theater. 12-20 the latter simplifies access, reduces case complexity, and provides for access to the abdominal cavity should an abdominal approach become necessary. finally, tamis may result in less short-term anal sphincter dysfunction than tem, because the tamis ports have a smaller diameter and are made of malleable material that allows for a conforming fit. although the effects of a tamis resection on sphincter function have not yet been studied, sphincter dysfunction has been shown by the use of the rigid 40-mm tem scope. 12, 50, 51 in this study, we describe the first 50 tamis excisions performed at our institution for diagnosis and treatment of benign and malignant tumors of the rectum. the recurrence rate at 20.2-month mean follow-up was 4.3%. this is similar to recurrence rates reported with tem. 10, 44 of the patients who underwent tamis excision for cancer, 3 proceeded to radical resection, and 1 of 19 (5.3%) demonstrated mural recurrence at 6-month follow-up. although this patient underwent repeat tamis excision with negative margins and has not demonstrated recurrence after subsequent reexcision, our success is tempered by data that reveal long-term cure for salvage surgery (including tem) is typically met with poor oncologic outcome. [52] [53] [54] three of our reported tamis excisions (6%) had positive margins. of the excisions for cancer, 1 of 23 (4.3%) had a positive margin, whereas 2 of 25 (8%) of tamis excisions for adenoma demonstrated positive margins. these findings compare favorably with those obtained with tem. in a recent publication by moore et al, 10 positive margins after tem excision of malignant lesions were 2%; tem rates of positive margins for benign adenoma, however, were found to be considerably higher at 17%. in this study, 4% of tamis excisions were fragmented, which is similar to fragmentation with tem (6%), yet significantly improved over Parks transanal excision (31%). 10 for the 6 patients who received tamis excision for t2/t3 cancer, 3 patients underwent immediate radical resection, which has been shown to have no adverse effect on oncologic outcome. 55 in this instance, tamis was used to perform an excisional biopsy, thereby providing a definitive t-stage. this removes uncertainty for the clinician and the patient, hence, verifying that radical resection is warranted to improve the chance of oncologic cure.
in this study, tamis has been shown to be safe and effective for excision of neoplastic lesions of the rectum. all 50 excisions were completed via tamis without conversion, although the peritoneal cavity was entered in 1 case (2%). this is lower than rates reported for tem, which can approach 10% in some series; however, this is largely biased by patient selection. 56, 57 this peritoneal violation occurred during local excision of a 4-cm villous adenoma 11.5 cm from the anal verge anteriorly without postoperative complications.
the use of tamis continues to expand. it has now been successfully performed with a variety of ports. 12, 14, [58] [59] [60] it has also been demonstrated by using robotic instrumentation for the successful resection of a rectal tumor. 61,62 furthermore, tamis has found application beyond local excision, including its use as a platform to facilitate repair of rectourethral fistulas, ileal J-pouch excision, and proctectomy. the latter has been done in a fashion similar to the transanal transabdominal approach described by marks et al. 63 Collectively, the results of this study, which demonstrate the efficacy of tamis for local excision, combined with its application beyond the excision of neoplasia, suggests that tamis is a versatile platform whose scope has yet to be fully realized.
CONCLUSION
tamis is a safe and effective advanced transanal platform for the local excision of benign adenomas and well-selected early-stage rectal cancer. Patient outcomes and resection quality appear to be similar to those obtained with tem; thus, tamis is a valid low-cost alternative to this established platform.
